ReviewBlood2025
Remestemcel-L-rknd (Ryoncil): the first approved cellular therapy for steroid-refractory acute GVHD.
Aaron Etra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ReviewBlood2025
Aaron Etra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.